Le Lézard
Classified in: Health
Subject: MRR

Neurovascular Intervention Devices Market Projected to Reach $6.21 billion by 2030 - Exclusive Report by 360iResearch


PUNE, India, May 2, 2024 /PRNewswire/ -- The report titled "Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Indication, End-use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $4.01 billion in 2023 to reach $6.21 billion by 2030, at a CAGR of 6.46% over the forecast period.

360iResearch Logo

"The Advancement of Minimally Invasive Devices Across the Globe"

Neurovascular disorders, conditions impacting the blood vessels of the brain and nervous system, are at the forefront of medical innovation with the advent of neurovascular intervention devices. Designed for precision, these devices, including stents, embolic coils, and clot retrieval tools, facilitate minimally invasive approaches to treat critical conditions such as aneurysms and strokes, significantly improving patient recovery times and outcomes. The demand for such advanced treatments is on a sharp rise due to the increasing incidence of neurovascular diseases globally, coupled with a growing preference for procedures that are less invasive than traditional surgery. This shift emphasizes the critical need for highly skilled specialists and state-of-the-art healthcare facilities, although challenges remain, including improved device navigability through complex vascular structures. Breakthroughs in technology, including the integration of AI and robotics, promise enhanced procedural accuracy and patient care. Regionally, the Americas lead with robust healthcare infrastructure and a focus on innovation, while the Asia-Pacific region witnesses rapid growth driven by healthcare development and an aging demographic. Europe's standardized regulatory framework supports the seamless introduction of safe, effective devices. This global landscape showcases a concerted effort towards advancing neurovascular care, prioritizing patient safety, and accessibility to cutting-edge treatments.

Download Sample Report @ https://www.360iresearch.com/library/intelligence/neurovascular-intervention-devices

"The Rise of Minimally Invasive Treatments"

The medical landscape is rapidly transforming, with an increasing emphasis on minimally invasive procedures, especially for neurovascular care. These innovative techniques highlight the remarkable progress in medical technology and approach, offering patients with required delicate brain and nerve treatments. Traditional surgeries, minimally invasive neurovascular interventions involve smaller incisions, leading to significantly less tissue damage, reduced infection risks, and a quicker recovery period. This shift not only elevates patient outcomes but also contributes to decreased healthcare costs, shorter hospital stays, and heightened patient satisfaction. The convergence of clinical benefits and technological advancements is propelling the need for these procedures, marking a pivotal turn in patient care and healthcare provider preferences.

"The Role of Neurovascular Intervention Devices in Modern Medicine"

Neurovascular intervention devices play a crucial role in stroke prevention and treatment in enhancing patient care. These tools, including balloon systems for angioplasty, ensure the reopening of narrowed or blocked brain arteries, improving blood circulation. Carotid stents support arteries to prevent collapse, which is crucial in preventing strokes in patients diagnosed with severe artery stenosis. Neurovascular catheters deliver essential drugs and devices precisely within the brain's intricate vasculature, aiding in various treatments. Embolic coils offer a preventive approach to brain aneurysms by promoting clot formation, thereby preventing rupture. Embolic protection devices safeguard patients by capturing debris during procedures, minimizing stroke risks. Flow diverters are revolutionizing the treatment of complex aneurysms by redirecting blood flow, leading to safer and more effective outcomes. Guidewires provide the necessary navigation within the brain's delicate arterial network, facilitating the accurate placement of these devices. Intracranial stents are essential in maintaining open blood vessels for patients with intracranial stenosis. Intrasaccular devices provide an innovative solution for aneurysm management, disrupting blood flow to encourage occlusion. Neurothrombectomy devices have transformed acute ischemic stroke treatment, allowing for the direct removal of clots. Stent retrievers efficiently extract large clots, representing a critical step forward in stroke management. These advances emphasize a promising direction in neurovascular care, emphasizing innovative, life-saving strategies.

Request Analyst Support @ https://www.360iresearch.com/library/intelligence/neurovascular-intervention-devices

"Stryker Corporation at the Forefront of Neurovascular Intervention Devices Market with a Strong 14.84% Market Share"

The key players in the Neurovascular Intervention Devices Market include Terumo Corporation, Stryker Corporation, Medtronic PLC, Penumbra, Inc., Johnson & Johnson Services, Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.

"Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Neurovascular Intervention Devices Market"

We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Neurovascular Intervention Devices Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Neurovascular Intervention Devices Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.

Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/neurovascular-intervention-devices

"Dive into the Neurovascular Intervention Devices Market Landscape: Explore 186 Pages of Insights, 490 Tables, and 24 Figures"

  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Neurovascular Intervention Devices Market, by Product
  7. Neurovascular Intervention Devices Market, by Process
  8. Neurovascular Intervention Devices Market, by Indication
  9. Neurovascular Intervention Devices Market, by End-use
  10. Americas Neurovascular Intervention Devices Market
  11. Asia-Pacific Neurovascular Intervention Devices Market
  12. Europe, Middle East & Africa Neurovascular Intervention Devices Market
  13. Competitive Landscape
  14. Competitive Portfolio

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/neurovascular-intervention-devices

Related Reports:

  1. Neurovascular Catheters Market - Global Forecast 2024-2030
  2. Brain Imaging Modalities Market - Global Forecast 2024-2030
  3. Neurovascular Devices Market - Global Forecast 2024-2030

About 360iResearch

Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset ? our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

Contact 360iResearch
Mr. Ketan Rohom
360iResearch Private Limited,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
Email: [email protected]
USA: +1-530-264-8485
India: +91-922-607-7550

To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.

Logo: https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg

 

SOURCE 360iResearch


These press releases may also interest you

at 03:00
Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide.  Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead...

at 03:00
At the Summit on Clean Cooking in Africa, World Resources Institute (WRI) and the Clean Cooking Alliance (CCA) announced a strategic partnership to further embed clean cooking into a broad range of sustainable development initiatives across the two...

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...



News published on and distributed by: